CONFLICT OF INTEREST
Haeberlin A. is Co-founder and CEO of Act-Inno AG, consultant of Cairdac
and has received travel/educational grants from Medtronic and
Spectranetics/Philips.
The spouse of Seiler J. is an employee of Boston Scientific.
Noti F. has received travel grant from Abbott, Medtronic, Boston
Scientific and Spectranetics.
Tanner H. has received travel grant from Abbott and educational grant
from Biosense Webster.
Windecker St. reports research and educational grants to the institution
from Abbott, Amgen, BMS, Bayer, Boston Scientific, Biotronik, Cardinal
Health, CardioValve, CSL Behring, Daiichi Sankyo, Edwards Lifesciences,
Johnson&Johnson, Medtronic, Querbet, Polares, Sanofi, Terumo, Sinomed.
Windecker St. serves as unpaid advisory board member and/or unpaid
member of the steering/executive group of trials funded by Abbott,
Abiomed, Amgen, Astra Zeneca, BMS, Boston Scientific, Biotronik,
Cardiovalve, Edwards Lifesciences, MedAlliance, Medtronic, Novartis,
Polares, Sinomed, V-Wave and Xeltis, but has not received personal
payments by pharmaceutical companies or device manufacturers. He is also
member of the steering/excecutive committee group of several
investigated-initiated trials that receive funding by industry without
impact on his personal remuneration. Windecker St. is an unpaid member
of the Pfizer Research Award selection committee in Switzerland.
Reichlin T. has received speaker/consulting honoraria or travel support
from Abbott/SJM, Astra Zeneca, Brahms, Bayer, Biosense-Webster,
Medtronic, Pfizer-BMS and Roche and he has received support for his
institution’s fellowship program from Biosense-Webster, Biotronik,
Medtronic, Abbott/SJM and Boston Scientific.
Roten L. has received speaker honoraria from Abbott and Medtronic. The
other authors have no potential conflict of interest relevant to this
article.